Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04925193 |
|---|---|
| Brief Title: | Personalized Selinexor-based Therapy for Relapsed/Refractory Multiple Myeloma |
| First Submitted : | May 19, 2021 |
| First Submitted that Met QC Criteria : | June 7, 2021 |
| First Posted : | June 14, 2021 |
| Last Update Submitted that Met QC Criteria : | February 2, 2024 |
| Last Update Posted : | February 5, 2024 |